IntroductionTo generate highly specific and highly effective antibodies, germinal center (GC) B cells undergo somatic hypermutation (SHM) and class switch recombination (CSR), 2 distinct processes that edit the variable region and the switch region of immunoglobulin (Ig) gene loci, respectively. SHM and CSR involve different types of DNA lesions yet are mediated by the common DNA editing enzyme, activation-induced cytidine deaminase (AID) that converts cytidine to uracil. The resulting uracil-guanidine mismatches are repaired by error-prone DNA repair mechanisms leading to the introduction of mutations. 1,2 Given its mutagenic nature, aberrant expression of AID is associated with the development of tumors based on the following observations: (1) AID transgenic mice develop various malignancies 3 ; (2) ectopic AID expression in cultured cells leads to genome-wide mutations 4 ; (3) aberrant AID expression coincides with accumulation of mutations in many proto-oncogenes of various malignant B cells 5 and in the tumor suppressor gene p53 in gastric cancer cells 6 ; and (4) in mice, AID is necessary for recapitulating chromosomal translocations involving the IgH locus, 7,8 a hallmark feature of many B-cell malignancies, 9,10 and plays a direct role in the development of GC-derived B-cell lymphomas. 11,12 Considering the mutagenic and oncogenic potential of AID, there is clear need for tight regulation of AID activity.Besides its aberrant expression, AID is also alternatively spliced into 4 mRNA variants in addition to the full-length (FL) form in B-cell malignancies including a subset of B-cell chronic lymphocytic leukemia (B-CLL) [13][14][15] and various types of B-cell lymphomas. 16,17 There is also limited evidence that AID alternative splicing may occur in normal B-lineage cells. 15,18 Despite its small size, the human AID protein possesses multiple functional domains. However, study of the functional activity of AID variants has not yet been reported. We hypothesize that alternative splicing would affect one or more of the major functional domains of AID thereby modulating enzymatic activity, which may be important for the physiological functions of AID in CSR and SHM and/or for its potential pathological role in tumorigenesis.Herein, we show that AID is alternatively spliced in normal human GC B cells and that AID expression in blood B cells is restricted to memory B cells. We also show for the first time that the naturally occurring truncated AID-splicing products possess selective functions in mediating SHM and CSR. Furthermore, we show that each individual B-cell expresses only one mRNA variant, suggesting that different B cells possess different capacities of fostering SHM and CSR at a given time. Individual AIDexpressing CLL B cells were also observed to express only a single AID isoform. Finally, CLL B cells, and to a much lesser degree normal memory B cells, exhibited higher levels of variant AID expression than did normal GC B cells. Collectively, these observations have implications for both the regula...